18 November 2026 - DDL, a third-party testing laboratory specialising in medical device and pharmaceutical packaging, combination products, and materials testing, announced on Tuesday that it has launched a new Pharmaceutical Consulting Services prog...
18 November 2026 - Ichnos Glenmark Innovation Inc (IGI), a clinical-stage biotechnology company focused on developing Multispecific therapeutics in oncology, announced on Tuesday the submission of an Investigational New Drug (IND) application to the ...
18 November 2026 - Inhibrx Biosciences Inc (Nasdaq:INBX), a clinical-stage biopharmaceutical company focused on developing novel biologic therapeutic candidates, announced on Tuesday updated clinical data from the Phase 1/2 expansion study evaluating...
18 November 2026 - Clinical-stage oncology company Onward Therapeutics Inc announced on Tuesday that it has closed its Series B financing of NTD900m (approximately USD28m).The round was raised in two closings, the second of which took place in Octobe...
18 November 2026 - Chinese biopharmaceutical company Harbour BioMed (HKEX:02142) announced on Tuesday that its partner Spruce Biosciences (Nasdaq:SPRB) has separated its CRHX-101 (formerly SPR-202 and HBM9013) programme into Adrenyx Biosciences.Adren...